Skip to Content

Phenergan 25mg film-coated tablets and Phenergan 5mg/5ml oral solution - new contraindication

06/11/2025
Medicines for human use Product information update (PIU)

This update is to inform healthcare professionals of a new contraindication for Phenergan oral administration in patients with known, documented long QT syndrome

Product information

Product name
Phenergan 5mg/5ml oral solution & Phenergan 25mg film-coated tablets
Active substance
promethazine hydrochloride
Authorisation holder
Opella Healthcare France SAS
Authorisation number
PA23180/011/001
PA23180/011/002

Documents

Opens in new window Phenergan Product Information Update October 2025 PDF : 157KB | 24/10/2025